Federated Hermes, Inc. Atea Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,442 shares of AVIR stock, worth $10,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,442

Previous 582,729 99.41%

Holding current value

$10,670

Previous $1.74 Million 99.31%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$2.55 - $3.6 $1.48 Million - $2.09 Million	-579,287 Reduced 99.41%	3,442 $12,000
Q1 2025 May 08, 2025	SELL	$2.9 - $3.52 $609 - $739	-210 Reduced 0.04%	582,729 $1.74 Million
Q4 2024 Feb 13, 2025	BUY	$2.93 - $3.82 $31,808 - $41,469	10,856 Added 1.9%	582,939 $1.95 Million
Q3 2024 Nov 13, 2024	BUY	$3.17 - $4.02 $2,583 - $3,276	815 Added 0.14%	572,083 $1.92 Million
Q2 2024 Aug 08, 2024	SELL	$3.31 - $4.04 $301 - $367	-91 Reduced 0.02%	571,268 $1.89 Million
Q1 2024 May 14, 2024	SELL	$3.09 - $4.56 $75,188 - $110,958	-24,333 Reduced 4.08%	571,359 $2.31 Million
Q4 2023 Jan 31, 2024	SELL	$2.8 - $3.35 $36,663 - $43,864	-13,094 Reduced 2.15%	595,692 $1.82 Million
Q3 2023 Nov 13, 2023	SELL	$3.0 - $3.79 $15,612 - $19,723	-5,204 Reduced 0.85%	608,786 $1.83 Million
Q2 2023 Aug 14, 2023	SELL	$3.21 - $5.06 $4.57 Million - $7.21 Million	-1,425,066 Reduced 69.89%	613,990 $2.3 Million
Q1 2023 May 08, 2023	SELL	$3.0 - $4.97 $3.13 Million - $5.18 Million	-1,041,841 Reduced 33.82%	2,039,056 $6.83 Million
Q4 2022 Feb 13, 2023	SELL	$4.35 - $6.17 $2.37 Million - $3.37 Million	-545,921 Reduced 15.05%	3,080,897 $14.8 Million
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $212,391 - $340,058	38,687 Added 1.08%	3,626,818 $20.6 Million
Q2 2022 Aug 15, 2022	BUY	$5.33 - $8.18 $8.19 Million - $12.6 Million	1,536,799 Added 74.92%	3,588,131 $25.5 Million
Q1 2022 May 13, 2022	BUY	$5.5 - $9.19 $11.3 Million - $18.9 Million	2,051,332 New	2,051,332 $14.8 Million

Others Institutions Holding AVIR

# of Institutions

110

Shares Held

48.9M

Call Options Held

Put Options Held

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $258M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Atea Pharmaceuticals, Inc. Transaction History